The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They ...

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) has earned a consensus recommendation of “Hold” from the fifteen analysts that are currently covering the firm, Marketbeat reports. Two equities ...

Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

Steward Partners Investment Advisory LLC acquired a new stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional ...

Learn more about whether Hims & Hers Health, Inc. or LifeStance Health Group, Inc. is a better investment based on AAII's A+ ...

The venture offshoot of the hedge fund giant Maverick Capital has backed companies including Hims&Hers and MosaicML.

Learn more about whether Alignment Healthcare, Inc. or Hims & Hers Health, Inc. is a better investment based on AAII's A+ ...

Whales with a lot of money to spend have taken a noticeably bearish stance on Hims & Hers Health. If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened ...

Hims reveals that while swiping left and right have become synonymous with dating culture among younger generations, the vast ...

First, Novo Nordisk is expanding its program to sell Wegovy GLP-1 weight loss drugs at discounted prices. Second, Novo is ...

While swiping left and right have become synonymous with dating culture among younger generations, a 2025 Hims study found ...